NEWLIMIT
Summary
NewLimit is a biotechnology company working to extend human healthspan by developing epigenetic reprogramming therapies.
Deals Overview
Total Deals0
Valued Deals0
Total Valuevalue n/a
Avg. Deal Sizevalue n/a
No teams exist
All rights reserved. Copyright © 2025 Datasite